United Smart Cities and Cure Pharmaceutical Announce Global Healthcare Initiative

United Smart Cities and drug delivery and development company, Cure Pharmaceutical, have announced a global healthcare awareness initiative.

In view of escalating healthcare costs, Cure and United Smart Cities will seek to promote education and innovation in delivering cost-effective and sustainable treatments to the world’s 7.3 billion population.

“We are happy to add Cure Pharmaceutical into United Smart Cities’ private sector partnership pool. Health infrastructure is a key focus area for the United Smart Cities programme, and we look forward to engaging with health solution providers from diverse sectors to jointly contribute to the development of robust, sustainable health infrastructure for smart sustainable cities worldwide,”

said Kari Eik, co-director United Smart Cities and secretary general of the Organisation for International Economic Relations (OiER).

“Cure was founded on the principles of affordability and global accessibility of medications. We are driven to finding healthcare solutions for people of all ages and demographics and we are honoured to be in service to this cause with United Smart Cities. Our mutual goal is to invigorate health and elevate living standards through education and sustainable new technologies,”

added Rob Davidson, CEO of Cure Pharmaceutical.

The United Smart Cities programme is a global multi-stakeholder initiative, established by the OiER in cooperation with the United Nations Economic Commission for Europe and other international organisations, cities, industry and finance sector.

Cure Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems.